Mr. Sudip Ghatak, Chief Technology Officer, brings over 25 years of medical diagnostics and device leadership in product development, innovation, strategy, and marketing to the ImmunoProfile^®  team. Prior to his role with ImmunoProfile^® , Mr. Ghatak held various management positions at Abbott Laboratories, Ikaria, PA Consulting Group, Sarnoff Corporation, and Genentech.
Mr. Ghatak holds Bachelor of Science and Arts degrees in Molecular and Cell Biology, and Geography from the Univeristy of California, Berkely, as well as a Masters of Business Administration in Finance and Marketing from New York University.

Mr. Rosenberg, Director, brings a wealth of experience from both the diagnostic and pharmaceutical industries. For four years he served as Senior Vice President and General Manager of Diagnostics for Bayer Healthcare North America. Previously, he held the Senior Vice President and General Manager position for Bayer Healthcare’s Pharmaceuticals division, overseeing the business in the United States. Mr. Rosenberg holds a Bachelor of Science from Boston State College and was awarded his MBA at the University of New Haven.

Mr. John H. Cellucci brings to ImmunoProfile^® over 30 years of operations experience on a global basis in manufacturing, product development sales, marketing, corporate development, mergers and acquisitions and legal skills. Prior to ImmunoProfile^®, he held various senior management positions including executive operational roles at companies like Johnson Controls, Deloitte Consulting, Fedders Corporation Air Conditioning and Public Service Electric & Gas. John has been a key manager and leader in a variety of business transactions for Fortune 500 companies. He holds a Bachelor of Arts from Villanova University, an MBA and JD from Widener University and an LLM from a joint program between University of Salzburg Austria and McGeorge School of Law. John holds a PMP certification and is licensed to practice law in the states of PA and NJ.

Mr. Sudip Ghatak, Chief Technology Officer, brings over 25 years of medical diagnostics and device leadership in product development, innovation, strategy, and marketing to the ImmunoProfile^® team. Prior to his role with ImmunoProfile^®, Mr. Ghatak held various management positions at Abbott Laboratories, Ikaria, PA Consulting Group, Sarnoff Corporation, and Genentech.
Mr. Ghatak holds Bachelor of Science and Arts degrees in Molecular and Cell Biology, and Geography from the Univeristy of California, Berkely, as well as a Masters of Business Administration in Finance and Marketing from New York University.

Mr. William Shea, Chief Executive Officer, comes to ImmunoProfile^® with over 40 years of experience in medical device leadership. He has serves as Chief Executive Officer of three medical companies and as a Board Member for over a dozen medical companies. Mr. Shea began his career at the Kendal Company (now part of Medtronic) and later served as CEO of New Dimensions in Medicine, the Clinipad Corporation, and Med-Ecom.

Mr. Shea has also consulted on numerous medical device transactions representing entrepreneurs with innovative technologies that fit in the portfolios of larger strategic medical companies. He holds a Bachelor of the Arts degree in Economics from The College if the Holy Cross and an Masters of Business Administration with a concentration in Marketing and Finance from Boston University.

Mr. Rosenberg, Director, brings a wealth of experience from both the diagnostic and pharmaceutical industries. For four years he served as Senior Vice President and General Manager of Diagnostics for Bayer Healthcare North America. Previously, he held the Senior Vice President and General Manager position for Bayer Healthcare’s Pharmaceuticals division, overseeing the business in the United States. Mr. Rosenberg holds a Bachelor of Science from Boston State College and was awarded his MBA at the University of New Haven.

Dr. Olivo is a physician scientist with over 40 years of experience in academia and industry in the fields of infectious disease and in vitro diagnostic test development. He holds multiple U.S. patents and has developed many diagnostic tests for viral and autoimmune diseases. He was the President and Chief Scientific Officer  at Apath, LLC, a hepatitis C virus (HCV)-focused company founded by Nobel laureate Dr. Charles Rice. During his tenure at Apath the company developed and licensed many of the virological tools used by the pharmaceutical industry to develop numerous anti-HCV drugs now used to cure HCV. Dr. Olivo was also the VP of R&D at Diagnostic Hybrids, Inc. an IVD manufacturer acquired by Quidel Corp. At Quidel he served as Senior Medical Director.

Dr. Olivo consults for and serves on the boards of multiple early-stage life science companies. He is a Managing Director and Venture Partner at two seed-stage investment firms. He is also an Adjunct Professor at Washington University Medical School in St. Louis. He received his medical and doctoral degrees from the University of Florida. He did his medical residency in Internal Medicine at the University of Wisconsin where he was chief medical resident. He did his postdoctoral training at the National Institutes of Health in the Laboratory of Viral Diseases.

John brings to ImmunoProfile^® over 30 years of operations experience on a global basis in manufacturing, product development sales, marketing, corporate development, mergers and acquisitions and legal skills. Prior to ImmunoProfile^®, he held various senior management positions including executive operational roles at companies like Johnson Controls, Deloitte Consulting and Fedders Air Conditioning and Public Service Electric & Gas. John has been a key manager and leader in a variety of business transactions for Fortune 500 companies. He holds a Bachelor of Arts from Villanova University, an MBA and JD from Widener University and an LLM from a joint program between University of Salzburg Austria and McGeorge School of Law. John holds a PMP certification and is licensed to practice law in the states of PA and NJ.